logo
welcome
TipRanks

TipRanks

Is Pfizer (NYSE:PFE) a High-Yielding Dividend Stock Worth Buying?

TipRanks
Summary
Nutrition label

81% Informative

Pfizer 's 5.9% dividend yield is more than quadruple the 1.3% yield of the S&P 500 index (SPX) Pfizer posted its third-quarter financial results on October 29th .

Pfizer looks like it is firmly on the road to recovery, which adds to my bullish outlook.

The company expects to realize $4 billion of its $5.5 billion -plus in annual targeted savings in 2024 .

Pfizer looks to offer significant value from the current $ 28 share price.

Pfizer is making progress toward reaching its gross leverage target of 3.25x .

The company’s interest coverage ratio through the first nine months of 2024 was 5.1x , which was enough for S&P Global to award an A credit rating.